dr. james on update of ibrutinib for chronic lymphocytic leukemia
Published 7 years ago • 666 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:20
dr. byrd provides an update on ibrutinib in cll
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
11:28
adverse events of ibrutinib in chronic lymphocytic leukemia
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
1:00
dr. smith on ibrutinib-based therapies in cll
-
1:22
dr. lee on cirmtuzumab/ibrutinib dosing in mcl and cll
-
4:07
management of cll progression after ibrutinib
-
5:54
updates from captivate: ibrutinib and venetoclax for cll
-
1:09
dr. byrd on long-term safety data with ibrutinib in cll
-
1:56
dr. abedin discusses key updates in cll
-
1:16
dr. jones on long-term outcomes with ibrutinib in cll
-
3:49
update on the captivate study for chronic lymphocytic leukemia patients
-
45:24
cll live 2015 - dr. james johnston, 'cll/sll and evolution of treatment'
-
1:57
updated data on ibrutinib therapy
-
1:55
dr. barr on updated resonate data in ighv-mutant cll
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
1:24
dr. richard furman on trials examining ibrutinib's safety in chroniclymphocytic leukemia